ISB News

Aitchison Lab Accepts ALS Ice Bucket Challenge

Jennifer Smith, senior research scientist in the John Aitchison Lab, was tagged to do the ALS Ice Bucket Challenge. And because the Aitchison group studies ALS, Jennifer’s lab mates took the challenge, too. Jennifer offered this description of the work they are doing to create a blood test for early detection of ALS:

ISB is developing a multi-component blood-based assay (blood test) for early detection and disease tracking of ALS. We are doing this because there are no good diagnostic tests for ALS and, on average, it takes a year to get a definitive diagnosis, resulting in significant loss of therapeutic opportunity. There is a dire need for a robust and quantitative blood biomarker assay to help confirm initial diagnosis of ALS and to track disease activity not only for clinical use, but to also to develop new therapies for the disease.

The assay we are developing is called the indicator cell assay platform (iCAP) for blood-based diagnostics that can be used for early detection of ALS, and as a diagnostic tool for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the natural ability of cells to detect signals present in serum from patients with ALS with exquisite sensitivity, as opposed to traditional assays that rely on direct detection of molecules in blood.

You can support ALSA.org to raise awareness about ALS. Or you can support ALS research directly with a gift to Institute for Systems Biology. Support ALS research directly.

You Have 24 Hours to Accept the Challenge!

And now, the Aitchison Lab challenges the following groups:

  • Mike Rout Lab, The Rockefeller University
  • Alan Aderem Lab, Seattle BioMed
  • Dave Goodlett Lab, University of Maryland

Learn more about the Aitchison Lab and Jennifer Smith. Jennifer received a “proof of concept” grant from the Life Sciences Discovery Fund to develop a similar early detection test for Alzheimer’s.

Ice Bucket Challenge Photo Gallery

You may also visit the full gallery on Flickr.

ALS5614 ALS5615 ALS5616

Related Articles

  • Dr. John Aitchison Taps Systems Biology, Collaboration to Attack Infectious Diseases

    John Aitchison is a pioneer in the field of systems biology. He is a founding member of Institute for Systems Biology (ISB), he was the long-time director of the Center for Systems Biology, and now he serves as president and director of Center for Infectious Disease Research (CIDR).

    Read More
  • New Study Identifies Organ-Specific Biomarkers for Acute Liver Injury

    ISB scientists recently published a study in the Journal of Proteome Research that presents results from a study on identifying organ-specific blood biomarkers for acute liver injury due to over-exposure to acetaminophen. From the summary: 3 Bullets: Finding organ-specific blood biomarkers for disease that are clinically useful is challenging. New study identifies organ-specific blood biomarkers for acute liver injury caused by over-exposure to acetaminophen. ISB researchers use the powerful, targeted…

    Read More
  • A New Approach to Identifying How the Deadly Dengue Virus Multiplies

    3 Bullets: Dengue virus is the most prevalent mosquito-borne virus worldwide, infecting an estimated 400 million people per year and causing about 25,000 deaths. It’s necessary to understand the molecular mechanisms of dengue replication in order to develop an effective treatment. Researchers at ISB and Seattle BioMed developed a novel approach for identifying host proteins that associate with dengue replication machinery. By Thurston Herricks Dengue virus (DENV) infects approximately 400…

    Read More
Show More Articles